Patent: 10,030,060
✉ Email this page to a colleague
Summary for Patent: 10,030,060
| Title: | Long-acting polypeptides and methods of producing same |
| Abstract: | A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a cytokine and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a cytokine are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed. |
| Inventor(s): | Fares; Fuad (Hourfish Village, IL), Fima; Udi Eyal (Beer-Sheva, IL) |
| Assignee: | OPKO Biologics Ltd. (Kiryat Gat, IL) |
| Application Number: | 14/566,370 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,030,060
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | January 15, 1974 | ⤷ Start Trial | 2034-12-10 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | December 27, 1984 | ⤷ Start Trial | 2034-12-10 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 15, 1985 | ⤷ Start Trial | 2034-12-10 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 16, 1990 | ⤷ Start Trial | 2034-12-10 |
| Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | March 26, 1974 | ⤷ Start Trial | 2034-12-10 |
| Fresenius Kabi Usa, Llc | CHORIONIC GONADOTROPIN | chorionic gonadotropin | For Injection | 017067 | March 05, 1973 | ⤷ Start Trial | 2034-12-10 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
